Annual Report

Overview

The report says Santen's fiscal 2014 revenue rose 10.6% to an all-time high of ¥161.8 billion. It describes the successive European launch of Ikervis from July 2015 and the company's plan to focus on ophthalmology after assigning its anti-rheumatic business. The report also sets out a company-wide target to reduce CO2 emissions by 23% by fiscal 2020 compared with fiscal 2005.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2014-2015
Period: 1 April 2014 – 31 March 2015
Language: English
Pages
File size
Restatement: Disclosed

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services